Global Healthcare REIT Inc (GBCS) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Global Healthcare REIT Inc $7.77, price $5.78, upside +34.4%, quality 51 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Global Healthcare REIT Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $1.00 – $11.00 · fair‑value band $3.80 – $13.50 · the $5.78 price screens below the $7.77 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 3 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 24, 2026.
Follow Global Healthcare REIT in your weekly email
Every Wednesday you see whether Global Healthcare REIT is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Selectis Health, Inc. owns and operates, through wholly-owned subsidiaries Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities across the South and Southeastern portions of the US.
Show more
Selectis Health, Inc. owns and operates, through wholly-owned subsidiaries Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities across the South and Southeastern portions of the US. The Company acquires, develops, leases and manages healthcare real estate and provides healthcare operations through our wholly-owned subsidiaries. Our portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. We will make investments within our healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008 (RIDEA), which represents investments in senior housing operations utilizing the structure permitted by RIDEA and (vi) owning healthcare operations. Selectis Health, Inc. was established and incorporated on June 08, 1978 in Utah, USA.
Stock analysis
Global Healthcare REIT Inc (GBCS) currently trades at $5.78, while our model-based Fair Value estimate is $7.77, implying the stock looks roughly 25.6% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $6.25 per share, and 6 of the 8 models we run sit above the $5.78 price.
Bear case: the Multiples group reads lowest at $2.06, and 2 of the 8 models stay below the price. Evidence for this calculation is medium.
Scenario range: $3.80 (bear) to $13.50 (bull), the price of $5.78 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Global Healthcare REIT Inc reported revenue of $41.4M in FY2025 versus $27.8M in FY2021, a compound +10.5%/yr. Reported net income was −$1.0M in FY2025.
Key figures
Market cap $17.7M · P/E ratio 3.2 · P/S ratio 0.26 · EPS (TTM) $1.78 · Dividend yield 0.0% · Net margin −2.5% · Return on equity −1,873% · Return on assets (EBIT) −7.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 1% below its 52-week high and 285% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at 34%, GBCS screens richer than that median.
Fair Value models
Bear $3.80Fair Value $7.77Bull $13.50
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($1.31 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.81/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+4.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.6%
Start year 2020 (pandemic). Over 10 years: +28.4% a year
Revenue growth 39 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
16.1% (2020) → −3.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+16.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +14.0% a year for the price.
Compare Global Healthcare REIT Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 258 stocks
Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score51 · Below median
Fair Value upside+34% · Above median
Profitability
Return on equity (TTM)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets−5% · Bottom 25%
Net margin (TTM)16% · Top 25%
Operating margin (TTM)−17% · Bottom 25%
Growth and dividend
Revenue growth−31% · Bottom 25%
Dividend yield (TTM)0.0% · Bottom 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (TTM)3.2× · Cheapest 25%
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM)0.46× · Cheapest 25%
P/FCF12.3× · Priciest 25%
PEG1.11× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)79· sector 33
FUTURE (revenue growth)0· sector 28
PAST (return on equity)0· sector 31
HEALTH (low debt)0· sector 89
DIVIDEND (yield)0· sector 43
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Global Healthcare REIT Inc (GBCS) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $7.77 versus a price of $5.78, about +34% upside (undervalued).
What is the fair value of GBCS?
Our model-based fair value for Global Healthcare REIT Inc is $7.77 (as of Sep 24, 2026), built from audited fundamentals. The current price: $5.78.
What is the quality score of GBCS?
Global Healthcare REIT Inc has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Global Healthcare REIT Inc (GBCS)?
Our model-based price target is the fair value of $7.77 (as of Sep 24, 2026) from 9 valuation models. Cautious scenario $3.80, optimistic scenario $13.50. It is a calculation from audited fundamentals, not an analyst target.
What is the Global Healthcare REIT Inc stock forecast for 2026?
Our models put fair value at $7.77, about +34% upside versus a price of $5.78 (undervalued). Cautious scenario $3.80, optimistic scenario $13.50. The calculation is refreshed regularly with new filings.
What is the revenue of Global Healthcare REIT Inc (GBCS)?
Global Healthcare REIT Inc reported trailing-twelve-month revenue of about $38.2M (latest available figure, as of Sep 24, 2026).
Does Global Healthcare REIT Inc pay a dividend?
Global Healthcare REIT Inc currently shows a dividend yield of about 0.01% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Global Healthcare REIT Inc (GBCS)?
For today's price to be fair in a discounted-cash-flow model, Global Healthcare REIT Inc would have to grow free cash flow by +16.7 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +14.6 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of GBCS use?
Our models discount Global Healthcare REIT Inc at 9.7 %: a base by market capitalisation (nano), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Global Healthcare REIT Inc that is +16.7 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has Global Healthcare REIT Inc (GBCS) delivered so far?
Over the past 5 years revenue at Global Healthcare REIT Inc grew +14.6 % a year. The price currently implies +16.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Global Healthcare REIT Inc (GBCS) growing?
The median revenue growth in the sector is +1.8 % a year. That is the yardstick for the growth priced into Global Healthcare REIT Inc (+16.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Global Healthcare REIT Inc (GBCS)?
The free-cash-flow yield on the price is 8.11 %: that much free cash flow Global Healthcare REIT Inc produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Global Healthcare REIT Inc (GBCS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Global Healthcare REIT Inc it is $7.77 per share (as of Sep 24, 2026), against a price of $5.78. It is the blended result of 9 valuation models (cash flow, earnings, asset, dividend).
Is Global Healthcare REIT Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, GBCS trades below its calculated fair value: price $5.78, fair value $7.77, a gap of about +34% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GBCS?
No. The price is what the market pays today ($5.78); the fair value is what the company's own numbers justify ($7.77). For Global Healthcare REIT Inc the two are $1.99 per share apart. That gap is exactly why we show both numbers side by side.
How much is Global Healthcare REIT Inc worth?
The market values Global Healthcare REIT Inc at about $17.7M (market capitalisation, as of Sep 24, 2026). Per share that is $5.78; our models calculate a fair value of $7.77 per share.
What do the bullish and bearish scenarios say about GBCS?
Our models span a range for Global Healthcare REIT Inc: cautious scenario $3.80, base $7.77, optimistic $13.50 per share (as of Sep 24, 2026, price $5.78). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of GBCS?
Global Healthcare REIT Inc trades at a price-to-earnings ratio of 3.2 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $7.77 is built from several models across several years. Other multiples: PEG 1.1, P/S 0.5.
What is the PEG ratio of GBCS?
The PEG ratio of Global Healthcare REIT Inc is 1.11 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Global Healthcare REIT Inc (GBCS)?
Balance-sheet figures for Global Healthcare REIT Inc (as of Sep 24, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is GBCS from its 52-week high?
Global Healthcare REIT Inc trades at $5.78, about 1% below its 52-week high of $5.83 and 285% above the low of $1.50 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $7.77 is for.
Which stocks are comparable to Global Healthcare REIT Inc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Global Healthcare REIT Inc stock attractive at the current price?
The data as of Sep 24, 2026: price $5.78, calculated fair value $7.77 (+34%), Quality Score 51/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GBCS calculated?
We run Global Healthcare REIT Inc through 9 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $7.77, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Global Healthcare REIT Inc currently trades 34 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Global Healthcare REIT Inc (GBCS)?
The closing price on Sep 23, 2026 was $5.78. Our model-based fair value is $7.77, about +34% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Global Healthcare REIT Inc right now?
The model range is unusually wide ($3.80 to $13.50). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Global Healthcare REIT Inc
How large is the market capitalisation of Global Healthcare REIT Inc (GBCS)?
The market capitalisation of Global Healthcare REIT Inc is $17.7M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Global Healthcare REIT Inc (GBCS)?
The price-to-sales ratio of Global Healthcare REIT Inc is 0.26 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Global Healthcare REIT Inc (GBCS)?
Earnings per share at Global Healthcare REIT Inc are $1.78 (price ÷ EPS = P/E 3.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Global Healthcare REIT Inc (GBCS)?
The dividend yield of Global Healthcare REIT Inc is 0.0% (payout 0.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Global Healthcare REIT Inc (GBCS)?
The net margin of Global Healthcare REIT Inc is −2.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Global Healthcare REIT Inc (GBCS)?
The return on equity (ROE) of Global Healthcare REIT Inc is −1,873% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Global Healthcare REIT Inc (GBCS)?
On an EBIT basis the return on assets of Global Healthcare REIT Inc is −7.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Global Healthcare REIT Inc (GBCS)?
The operating margin of Global Healthcare REIT Inc is −17.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Global Healthcare REIT Inc (GBCS)?
Revenue at Global Healthcare REIT Inc is growing −30.5% versus a year earlier (3y avg +0.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Global Healthcare REIT Inc (GBCS)?
Earnings per share at Global Healthcare REIT Inc are growing +17.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Global Healthcare REIT Inc (GBCS) carry?
The net debt of Global Healthcare REIT Inc is $24.4M (fiscal year 2025, ≈ 17.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Global Healthcare REIT Inc in the live analysis
One click puts Global Healthcare REIT Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Some data
Sep 24, 2026